{"id":31149,"date":"2026-08-29T14:01:30","date_gmt":"2026-08-29T14:01:30","guid":{"rendered":"https:\/\/sorapeptides.com\/peptidi-za-fokus-semax-pinealon-orexin-a\/"},"modified":"2026-09-11T22:24:19","modified_gmt":"2026-09-11T22:24:19","slug":"peptidy-koncentrace-semax-pinealon-orexin-a","status":"publish","type":"post","link":"https:\/\/sorapeptides.com\/cs\/peptidy-koncentrace-semax-pinealon-orexin-a\/","title":{"rendered":"Peptidy na koncentraci: Semax, Pinealon, Orexin-A a Selank ve v\u00fdzkumu"},"content":{"rendered":"<p>V\u00fdraz \u201epeptidy pro soust\u0159ed\u011bn\u00ed\u201c se st\u00e1le \u010dast\u011bji objevuje v textech o koncentraci, bd\u011blosti a kognitivn\u00edch funkc\u00edch. Za touto kr\u00e1tkou fr\u00e1z\u00ed se v\u0161ak skr\u00fdvaj\u00ed velmi r\u016fzn\u00e9 molekuly, r\u016fzn\u00e9 mechanismy p\u016fsoben\u00ed a d\u016fkazy nestejn\u00e9 kvality. Semax, Pinealon, Orexin-A a Selank jsou dobr\u00fdm p\u0159\u00edkladem: v\u0161echny \u010dty\u0159i se spojuj\u00ed s funkcemi nervov\u00e9ho syst\u00e9mu, ale nelze je pova\u017eovat za t\u0159i verze t\u00e9\u017ee l\u00e1tky.<\/p>\n<p>Tento text vysv\u011btluje, co se o nich zkoum\u00e1, kde byly v\u00fdsledky z\u00edsk\u00e1ny a kter\u00e9 hranice sou\u010dasn\u00fdch \u00fadaj\u016f nen\u00ed dobr\u00e9 p\u0159eskakovat.<\/p>\n<h2>Co jsou peptidy a pro\u010d p\u0159itahuj\u00ed pozornost v\u00fdzkumn\u00edk\u016f?<\/h2>\n<p><a href=\"https:\/\/sorapeptides.com\/cs\/co-jsou-peptidy\/\">Peptidy jsou kr\u00e1tk\u00e9 \u0159et\u011bzce<\/a> aminokyselin. V organismu se mnoh\u00e9 z nich \u00fa\u010dastn\u00ed p\u0159enosu sign\u00e1l\u016f mezi bu\u0148kami, regulace hormon\u016f, odpov\u011bdi na stres a \u010dinnosti nervov\u00e9ho syst\u00e9mu. Pr\u00e1v\u011b tato schopnost selektivn\u011b se v\u00e1zat na ur\u010dit\u00e9 receptory \u010din\u00ed z peptid\u016f zaj\u00edmav\u00e9 kandid\u00e1ty pro v\u00fdzkum.<\/p>\n<p>Probl\u00e9m je, \u017ee v\u00fdsledky z\u00edskan\u00e9 v bun\u011b\u010dn\u00fdch kultur\u00e1ch nebo na zv\u00ed\u0159atech se \u010dasto p\u0159\u00edli\u0161 brzy prezentuj\u00ed jako d\u016fkaz \u00fa\u010dinku u zdrav\u00fdch lid\u00ed. Shoda biologick\u00e9ho mechanismu a klinicky potvrzen\u00e9ho v\u00fdsledku nen\u00ed tot\u00e9\u017e. Pro odpov\u011bdn\u00e9 posouzen\u00ed je v\u017edy t\u0159eba se pt\u00e1t: na kom byl v\u00fdzkum proveden, jakou cestou byla l\u00e1tka pod\u00e1na, kolik \u00fa\u010dastn\u00edk\u016f se z\u00fa\u010dastnilo a zda byl stejn\u00fd v\u00fdsledek zopakov\u00e1n v nez\u00e1visl\u00e9 studii.<\/p>\n<h2>Semax: peptidov\u00fd analog spojovan\u00fd se signalizac\u00ed BDNF<\/h2>\n<p>Semax je syntetick\u00fd peptid odvozen\u00fd z fragmentu adrenokortikotropn\u00edho hormonu ACTH(4\u201310), ale bez klasick\u00e9 hormon\u00e1ln\u00ed aktivity ACTH. Nejv\u00edce v\u00fdzkumu o n\u011bm poch\u00e1z\u00ed z Ruska a ze zem\u00ed b\u00fdval\u00e9ho Sov\u011btsk\u00e9ho svazu.<\/p>\n<p>V experiment\u00e1ln\u00edch modelech byl Semax spojov\u00e1n se zm\u011bnami exprese BDNF, tedy mozkov\u00e9ho neurotrofn\u00edho faktoru. BDNF se pod\u00edl\u00ed na plasticit\u011b nervov\u00e9ho syst\u00e9mu, u\u010den\u00ed a tvorb\u011b pam\u011bti. Studie na zv\u00ed\u0159atech uk\u00e1zaly, \u017ee intranaz\u00e1ln\u00ed pod\u00e1n\u00ed m\u016f\u017ee m\u011bnit expresi BDNF a NGF v n\u011bkter\u00fdch \u010d\u00e1stech mozku. Existuj\u00ed i star\u0161\u00ed pr\u00e1ce popisuj\u00edc\u00ed zm\u011bny pozornosti a pam\u011bti u lid\u00ed, ale d\u016fkazn\u00e1 z\u00e1kladna je men\u0161\u00ed a metodologicky nevyrovnan\u011bj\u0161\u00ed, ne\u017e jakou vy\u017eaduje \u0161iroce p\u0159ijat\u00e9 terapeutick\u00e9 doporu\u010den\u00ed.<\/p>\n<p>Proto je p\u0159esn\u011bj\u0161\u00ed \u0159\u00edci, \u017ee Semax m\u00e1 v\u00fdzkumn\u00fd z\u00e1jem v oblasti kognitivn\u00edch funkc\u00ed, ne\u017e tvrdit, \u017ee je prok\u00e1zan\u00fdm \u201eprost\u0159edkem na koncentraci\u201c pro b\u011b\u017enou populaci.<\/p>\n<h2>Selank: tuftsinov\u00fd peptid ze stejn\u00e9 linie jako Semax<\/h2>\n<p>Selank je syntetick\u00fd heptapeptid vznikl\u00fd modifikac\u00ed tuftsinu, kr\u00e1tk\u00e9ho fragmentu imunoglobulinu. Byl vyvinut ve stejn\u00e9m rusk\u00e9m institutu jako Semax a v literatu\u0159e se nej\u010dast\u011bji popisuje jako anxiolytikum, tedy molekula zkouman\u00e1 v kontextu nap\u011bt\u00ed a \u00fazkosti, a ne jako stimulant.<\/p>\n<p>Publikovan\u00e9 pr\u00e1ce zva\u017euj\u00ed vliv na GABAergn\u00ed a serotonergn\u00ed signalizaci, na expresi gen\u016f spojen\u00fdch s imunitn\u00edmi a neurotrofn\u00edmi faktory a na chov\u00e1n\u00ed v experiment\u00e1ln\u00edch modelech. Existuje i men\u0161\u00ed po\u010det rusk\u00fdch klinick\u00fdch zpr\u00e1v u \u00fazkostn\u00fdch poruch, ale mimo tento r\u00e1mec jsou nez\u00e1visl\u00e9 studie vz\u00e1cn\u00e9, vzorky mal\u00e9 a metodologie nevyrovnan\u00e1.<\/p>\n<p>Zde je d\u016fle\u017eit\u00e9 odd\u011blit dv\u011b v\u011bci, kter\u00e9 marketing \u010dasto spojuje. Selank se n\u011bkdy prezentuje jako n\u00e1hrada stimulant\u016f typu amfetaminov\u00fdch l\u00e9k\u016f na p\u0159edpis. To nen\u00ed pravda: jde o zcela jin\u00fd mechanismus, bez dopaminov\u00e9ho stimula\u010dn\u00edho \u00fa\u010dinku, kter\u00fd tyto l\u00e9ky maj\u00ed. Takov\u00e1 porovn\u00e1n\u00ed nem\u00e1 literatura podlo\u017een\u00e1 a nem\u011bla by slou\u017eit jako podklad pro rozhodnut\u00ed.<\/p>\n<h2>Pinealon: kr\u00e1tk\u00fd peptid EDR s omezen\u00fdmi klinick\u00fdmi \u00fadaji<\/h2>\n<p>Pinealon je tripeptid slo\u017een\u00fd z kyseliny glutamov\u00e9, kyseliny asparagov\u00e9 a argininu, proto se ozna\u010duje jako peptid EDR. V literatu\u0159e se nej\u010dast\u011bji zva\u017euje v kontextu bun\u011b\u010dn\u00e9 odpov\u011bdi na oxida\u010dn\u00ed stres, regulace genov\u00e9 exprese a proces\u016f spojen\u00fdch se st\u00e1rnut\u00edm nervov\u00e9ho syst\u00e9mu.<\/p>\n<p>Velk\u00e1 \u010d\u00e1st publikovan\u00fdch v\u00fdsledk\u016f poch\u00e1z\u00ed z bun\u011b\u010dn\u00fdch a zv\u00ed\u0159ec\u00edch model\u016f. Existuj\u00ed pr\u00e1ce popisuj\u00edc\u00ed neuroprotektivn\u00ed \u00fa\u010dinky a zm\u011bny v chov\u00e1n\u00ed pokusn\u00fdch zv\u00ed\u0159at, stejn\u011b jako men\u0161\u00ed po\u010det klinick\u00fdch zpr\u00e1v u star\u0161\u00edch osob se slo\u017eit\u00fdm zdravotn\u00edm stavem. To nen\u00ed tot\u00e9\u017e co d\u016fkaz, \u017ee Pinealon zlep\u0161uje soust\u0159ed\u011bn\u00ed u zdrav\u00fdch lid\u00ed.<\/p>\n<p>Obzvl\u00e1\u0161\u0165 d\u016fle\u017eit\u00e9 je, \u017ee n\u00e1lezy o jednotliv\u00e9m peptidu nelze automaticky p\u0159en\u00e9st na kombinaci v\u00edce peptid\u016f. Stabilitu, vst\u0159eb\u00e1v\u00e1n\u00ed a vz\u00e1jemn\u00e9 interakce je t\u0159eba zkoumat pro konkr\u00e9tn\u00ed formulaci.<\/p>\n<h2>Orexin-A: sign\u00e1l bd\u011blosti, ne obvykl\u00fd stimulant<\/h2>\n<p>Orexin-A, zn\u00e1m\u00fd tak\u00e9 jako hypokretin-1, je p\u0159irozen\u00fd neuropeptid, kter\u00fd tvo\u0159\u00ed neurony hypotalamu. Orexinov\u00fd syst\u00e9m m\u00e1 d\u016fle\u017eitou roli v udr\u017eov\u00e1n\u00ed bd\u011blosti, regulaci cyklu sp\u00e1nku a bd\u011bn\u00ed, motivaci a energetick\u00e9 rovnov\u00e1ze.<\/p>\n<p>Nejjasn\u011bj\u0161\u00ed spojen\u00ed mezi orexinem a lidskou nemoc\u00ed je vid\u011bt u narkolepsie typu 1, kde je orexinov\u00e1 signalizace v\u00e1\u017en\u011b naru\u0161en\u00e1. Mal\u00e9 kontrolovan\u00e9 studie intranaz\u00e1ln\u00edho Orexinu-A u osob s narkolepsi\u00ed zaznamenaly zm\u011bny ve stabilit\u011b REM sp\u00e1nku a v n\u011bkter\u00fdch testech pozornosti. Ve studii na jin\u00fdch ne\u017e lidsk\u00fdch prim\u00e1tech zlep\u0161ilo nosn\u00ed i nitro\u017e\u00edln\u00ed pod\u00e1n\u00ed v\u00fdkon b\u011bhem sp\u00e1nkov\u00e9 deprivace.<\/p>\n<p>Tyto v\u00fdsledky jsou zaj\u00edmav\u00e9, ale jsou v\u00e1z\u00e1ny na specifick\u00e9 experiment\u00e1ln\u00ed podm\u00ednky \u2013 narkolepsii nebo v\u00fdrazn\u00fd nedostatek sp\u00e1nku. Nedokazuj\u00ed, \u017ee je Orexin-A univerz\u00e1ln\u00edm \u0159e\u0161en\u00edm pro produktivitu, ani \u017ee je bezpe\u010dn\u00fd p\u0159i nekontrolovan\u00e9m pou\u017eit\u00ed.<\/p>\n<h2>Pro\u010d se zva\u017euje kombinace t\u011bchto \u010dty\u0159 peptid\u016f?<\/h2>\n<p>Koncept kombinace Semaxu, Pinealonu, Orexinu-A a Selanku vych\u00e1z\u00ed z toho, \u017ee molekuly pat\u0159\u00ed do r\u016fzn\u00fdch v\u00fdzkumn\u00fdch sm\u011br\u016f:<\/p>\n<ul>\n<li><strong>Semax<\/strong> se zva\u017euje p\u0159es neurotrofn\u00ed signalizaci a kognitivn\u00ed procesy;<\/li>\n<li><strong>Pinealon<\/strong> p\u0159es kr\u00e1tk\u00e9 regula\u010dn\u00ed peptidy a bun\u011b\u010dnou ochranu;<\/li>\n<li><strong>Orexin-A<\/strong> p\u0159es syst\u00e9m bd\u011blosti a stabilizaci stavu sp\u00e1nku a bd\u011bn\u00ed;<\/li>\n<li><strong>Selank<\/strong> p\u0159es anxiolytickou signalizaci a sn\u00ed\u017een\u00ed nap\u011bt\u00ed.<\/li>\n<\/ul>\n<p>Je to racion\u00e1ln\u00ed v\u00fdzkumn\u00e1 my\u0161lenka, ale nen\u00ed to d\u016fkaz \u00fa\u010dinku samotn\u00e9 kombinace. K posouzen\u00ed komplexu jsou pot\u0159eba \u00fadaje o stabilit\u011b formulace, farmakokinetice, pom\u011bru slo\u017eek, mo\u017en\u00fdch interakc\u00edch a kontrolovan\u00fdch v\u00fdsledc\u00edch u lid\u00ed.<\/p>\n<h2>Jak\u00fd je dnes nejpoctiv\u011bj\u0161\u00ed z\u00e1v\u011br?<\/h2>\n<p>Semax, Pinealon, Orexin-A a Selank p\u0159edstavuj\u00ed \u010dty\u0159i r\u016fzn\u00e9 peptidov\u00e9 sm\u011bry spojen\u00e9 s nervov\u00fdm syst\u00e9mem. U Semaxu a Orexinu-A existuj\u00ed v\u00fdzkumy u lid\u00ed, ale v omezen\u00fdch populac\u00edch a se specifick\u00fdmi protokoly. U Pinealonu p\u0159eva\u017euj\u00ed preklinick\u00e9 a \u010dasn\u00e9 \u00fadaje. Pevn\u00e1 kombinace t\u011bchto peptid\u016f by se nem\u011bla prezentovat jako klinicky potvrzen\u00e1 terapie.<\/p>\n<p>Na str\u00e1nce <a href=\"https:\/\/sorapeptides.com\/cs\/peptidy-koncentrace\/\">peptidov\u00e9ho komplexu SORA Focus<\/a> si m\u016f\u017eete prohl\u00e9dnout deklarovan\u00e9 slo\u017een\u00ed a obsah sady. Prezentace produktu je informativn\u00ed a nenahrazuje l\u00e9ka\u0159skou radu, diagn\u00f3zu ani terapii.<\/p>\n<h2>Zdroje<\/h2>\n<ul>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16996037\/\" target=\"_blank\" rel=\"noopener\">Semax a signalizace BDNF\/trkB<\/a><\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18756821\/\" target=\"_blank\" rel=\"noopener\">Zm\u011bny exprese BDNF a NGF po Semaxu<\/a><\/li>\n<li><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7795577\/\" target=\"_blank\" rel=\"noopener\">P\u0159ehled v\u00fdzkumu peptidu EDR Pinealon<\/a><\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24406723\/\" target=\"_blank\" rel=\"noopener\">Intranaz\u00e1ln\u00ed Orexin-A u narkolepsie<\/a><\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18160631\/\" target=\"_blank\" rel=\"noopener\">Nosn\u00ed pod\u00e1n\u00ed Orexinu-A v modelu sp\u00e1nkov\u00e9 deprivace<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Co se dnes v\u00ed o Semaxu, Pinealonu a Orexinu-A, jak siln\u00e9 jsou d\u016fkazy a pro\u010d se tyto t\u0159i peptidy zkoumaj\u00ed v kontextu soust\u0159ed\u011bn\u00ed.<\/p>\n","protected":false},"author":1,"featured_media":31150,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[227],"tags":[],"class_list":["post-31149","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptidy"],"_links":{"self":[{"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/posts\/31149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/comments?post=31149"}],"version-history":[{"count":3,"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/posts\/31149\/revisions"}],"predecessor-version":[{"id":32610,"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/posts\/31149\/revisions\/32610"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/media\/31150"}],"wp:attachment":[{"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/media?parent=31149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/categories?post=31149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sorapeptides.com\/cs\/wp-json\/wp\/v2\/tags?post=31149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}